Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • Intensive Glycemic Control and Renal Outcome

    Contributions to Nephrology Date published:

  • Managing cardiovascular risk in people with chronic kidney disease: a review of the evidence from randomized controlled trials

    Therapeutic Advances in Chronic Disease Date published:

  • Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and combined therapy in patients with micro- and macroalbuminuria and other cardiovascular risk factors: a systematic review of randomized controlled trials

    Nephrology Dialysis Transplantation Date published:

  • Challenges of conducting a trial of uric-acid-lowering therapy in CKD

    Nature Reviews Nephrology Date published:

  • OUTCOMES OF PATIENTS RECEIVING EXTENDED HOURS HAEMODIALYSIS (EHHD)

    Date published:

  • Intensive glucose lowering and end stage kidney disease: new data from the ADVANCE trial

    Date published:

  • Risk of major renal events in people with type 2 diabetes: prediction models based on the ADVANCE study population

    Date published:

  • NEW MODELS FOR THE PREDICTION OF EARLY AND LATE RENAL EVENTS IN TYPE 2 DIABETES

    Date published:

  • INTENSIVE GLUCOSE LOWERING AND END STAGE KIDNEY DISEASE - NEW DATA FROM THE ADVANCE TRIAL

    Date published:

  • CIRCULATING BONE MORPHOGENETIC PROTEIN-7 (BMP7) AND TRANSFORMING GROWTH FACTOR-beta 1 (TGF beta 1) AS POTENTIAL BIOMARKERS FOR RENAL ENDPOINTS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS

    Date published:

  • AGE AND CO-MORBIDITY, BUT NOT ESA DOSE OR HAEMOGLOBIN, ARE IMPORTANT ASSOCIATIONS WITH MORTALITY IN A PROSPECTIVELY FOLLOWED COHORT OF DIALYSIS PATIENTS

    Date published:

  • Is Doubling of Serum Creatinine a Valid Clinical ‘Hard’ Endpoint in Clinical Nephrology Trials

    Nephron Clinical Practice Date published:

  • Pre-operative Kidney Function as a Predictor of Adverse Outcomes after Surgery-A Systematic Review and Meta-analysis

    Heart, Lung and Circulation Date published:

  • The effects of blood pressure reduction and of different blood pressure-lowering regimens on major cardiovascular events according to baseline blood pressure: meta-analysis of randomized trials

    Journal of Hypertension Date published:

  • Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease

    American Heart Journal Date published:

  • Prognostic value of CRP in stable coronary artery disease unclear due to a variety of biases in existing studies, therefore no clinical practice recommendations can be made

    Evidence-Based Medicine Date published: